N
Navotek Medical
Real-time innovative tracking and navigation solutions for medical applications
About Navotek Medical
Navotek Medical Ltd. is a medical technology company focused on improving the accuracy and effectiveness of radiation therapy. Founded in 2017 by CEO Udi Vainshtein, the company is headquartered in Yokneam, Israel. Vainshtein brings over two decades of experience in research and development within the medical device industry, having held significant roles at companies like Given Imaging and Philips, which provides a strong foundation for his leadership at Navotek.
The company's core technology is RealTrack, an intra-body tracking system designed to precisely monitor the location of tumors and organs in real-time during radiation treatment. This technology is incorporated into their flagship product, RealEye, which functions as a patient positioning and target monitoring system for radiation therapy. RealEye utilizes fiducial markers, which are small objects placed in or near a tumor, to provide highly accurate, real-time 3D tracking of the target area. This capability addresses a critical challenge in radiotherapy: the movement of tumors and organs due to processes like breathing.
By continuously monitoring the target's position, the RealEye system aims to ensure that the radiation beam is accurately delivered to the cancerous tissue while minimizing exposure to surrounding healthy organs. This leads to more effective treatments and a reduction in potential side effects for patients. The system is designed to seamlessly integrate with existing radiation therapy equipment, making it a practical addition to clinical workflows. Navotek Medical operates within the medical device and oncology market, targeting hospitals and cancer treatment centers as its primary clients. Its business model likely revolves around the sale of the RealEye system and potentially recurring revenue from software, support, or disposable components associated with the tracking technology.
Source: Dealroom company dataNews
Open roles
Navotek Medical in the Yokneam Ilit ecosystem
The Navotek Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Giza Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Navotek Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Navotek Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

